Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas

Roger D. Klein, Long Jin, Kandelaria Rumilla, William Francis Young, Ricardo V. Lloyd

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Germline mutations in the genes encoding the B (SDHB) and D (SDHD) subunits of the heterotetrameric protein succinate dehydrogenase (mitochondrial complex II) are important causes of inherited and apparently sporadic paragangliomas. In an effort to further investigate the role of these genes in malignant sympathetic paragangliomas and adrenal pheochromocytomas, we screened a series of tumors for mutations in SDHB and SDHD. Mutation testing was performed on DNA extracted from formalin-fixed, paraffin-embedded tumors and associated normal tissues by polymerase chain reaction amplification and direct sequencing of the coding regions and intron-exon junctions of the SDHB and SDHD genes. Among 16 malignant paragangliomas with proven metastases, 6 (38%) had mutations in SDHB (2 nonsense, 1 splice site, 1 insertion causing a frameshift, and 2 presumably deleterious missense mutations). Probable deleterious SDHB variants were also detected in 5 (45%) of 11 paragangliomas without known metastatic disease (1 splice site, 1 deletion causing a frameshift, and 3 missense changes). In 12 malignant pheochromocytomas, 1 SDHD and no SDHB mutations were identified. The identical SDHB mutation was detected in DNA extracted from accompanying normal tissue for each of the 10 cases on which this analysis was performed. An excess of SDHB mutations in paragangliomas versus pheochromocytomas was found, with no difference in the frequency of mutations in malignant versus benign paragangliomas. The disparate mutational spectra in malignant paragangliomas and pheochromocytomas may reflect differences in underlying tumor biology.

Original languageEnglish (US)
Pages (from-to)94-100
Number of pages7
JournalDiagnostic Molecular Pathology
Volume17
Issue number2
DOIs
StatePublished - Jun 2008

Fingerprint

Paraganglioma
Germ-Line Mutation
Pheochromocytoma
Mutation
Genes
Neoplasms
Succinate Dehydrogenase
DNA
Protein Subunits
Mutation Rate
Missense Mutation
Paraffin
Introns
Formaldehyde
Exons
Neoplasm Metastasis
Polymerase Chain Reaction

Keywords

  • Chromaffin tumor
  • Mitochondrial complex II
  • Paraganglioma
  • Pheochromocytoma
  • SDHB
  • SDHD
  • Succinate dehydrogenase

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas. / Klein, Roger D.; Jin, Long; Rumilla, Kandelaria; Young, William Francis; Lloyd, Ricardo V.

In: Diagnostic Molecular Pathology, Vol. 17, No. 2, 06.2008, p. 94-100.

Research output: Contribution to journalArticle

Klein, Roger D. ; Jin, Long ; Rumilla, Kandelaria ; Young, William Francis ; Lloyd, Ricardo V. / Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas. In: Diagnostic Molecular Pathology. 2008 ; Vol. 17, No. 2. pp. 94-100.
@article{c12e3dbb80284a75bb86d480151411f3,
title = "Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas",
abstract = "Germline mutations in the genes encoding the B (SDHB) and D (SDHD) subunits of the heterotetrameric protein succinate dehydrogenase (mitochondrial complex II) are important causes of inherited and apparently sporadic paragangliomas. In an effort to further investigate the role of these genes in malignant sympathetic paragangliomas and adrenal pheochromocytomas, we screened a series of tumors for mutations in SDHB and SDHD. Mutation testing was performed on DNA extracted from formalin-fixed, paraffin-embedded tumors and associated normal tissues by polymerase chain reaction amplification and direct sequencing of the coding regions and intron-exon junctions of the SDHB and SDHD genes. Among 16 malignant paragangliomas with proven metastases, 6 (38{\%}) had mutations in SDHB (2 nonsense, 1 splice site, 1 insertion causing a frameshift, and 2 presumably deleterious missense mutations). Probable deleterious SDHB variants were also detected in 5 (45{\%}) of 11 paragangliomas without known metastatic disease (1 splice site, 1 deletion causing a frameshift, and 3 missense changes). In 12 malignant pheochromocytomas, 1 SDHD and no SDHB mutations were identified. The identical SDHB mutation was detected in DNA extracted from accompanying normal tissue for each of the 10 cases on which this analysis was performed. An excess of SDHB mutations in paragangliomas versus pheochromocytomas was found, with no difference in the frequency of mutations in malignant versus benign paragangliomas. The disparate mutational spectra in malignant paragangliomas and pheochromocytomas may reflect differences in underlying tumor biology.",
keywords = "Chromaffin tumor, Mitochondrial complex II, Paraganglioma, Pheochromocytoma, SDHB, SDHD, Succinate dehydrogenase",
author = "Klein, {Roger D.} and Long Jin and Kandelaria Rumilla and Young, {William Francis} and Lloyd, {Ricardo V.}",
year = "2008",
month = "6",
doi = "10.1097/PDM.0b013e318150d67c",
language = "English (US)",
volume = "17",
pages = "94--100",
journal = "Diagnostic Molecular Pathology",
issn = "1052-9551",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas

AU - Klein, Roger D.

AU - Jin, Long

AU - Rumilla, Kandelaria

AU - Young, William Francis

AU - Lloyd, Ricardo V.

PY - 2008/6

Y1 - 2008/6

N2 - Germline mutations in the genes encoding the B (SDHB) and D (SDHD) subunits of the heterotetrameric protein succinate dehydrogenase (mitochondrial complex II) are important causes of inherited and apparently sporadic paragangliomas. In an effort to further investigate the role of these genes in malignant sympathetic paragangliomas and adrenal pheochromocytomas, we screened a series of tumors for mutations in SDHB and SDHD. Mutation testing was performed on DNA extracted from formalin-fixed, paraffin-embedded tumors and associated normal tissues by polymerase chain reaction amplification and direct sequencing of the coding regions and intron-exon junctions of the SDHB and SDHD genes. Among 16 malignant paragangliomas with proven metastases, 6 (38%) had mutations in SDHB (2 nonsense, 1 splice site, 1 insertion causing a frameshift, and 2 presumably deleterious missense mutations). Probable deleterious SDHB variants were also detected in 5 (45%) of 11 paragangliomas without known metastatic disease (1 splice site, 1 deletion causing a frameshift, and 3 missense changes). In 12 malignant pheochromocytomas, 1 SDHD and no SDHB mutations were identified. The identical SDHB mutation was detected in DNA extracted from accompanying normal tissue for each of the 10 cases on which this analysis was performed. An excess of SDHB mutations in paragangliomas versus pheochromocytomas was found, with no difference in the frequency of mutations in malignant versus benign paragangliomas. The disparate mutational spectra in malignant paragangliomas and pheochromocytomas may reflect differences in underlying tumor biology.

AB - Germline mutations in the genes encoding the B (SDHB) and D (SDHD) subunits of the heterotetrameric protein succinate dehydrogenase (mitochondrial complex II) are important causes of inherited and apparently sporadic paragangliomas. In an effort to further investigate the role of these genes in malignant sympathetic paragangliomas and adrenal pheochromocytomas, we screened a series of tumors for mutations in SDHB and SDHD. Mutation testing was performed on DNA extracted from formalin-fixed, paraffin-embedded tumors and associated normal tissues by polymerase chain reaction amplification and direct sequencing of the coding regions and intron-exon junctions of the SDHB and SDHD genes. Among 16 malignant paragangliomas with proven metastases, 6 (38%) had mutations in SDHB (2 nonsense, 1 splice site, 1 insertion causing a frameshift, and 2 presumably deleterious missense mutations). Probable deleterious SDHB variants were also detected in 5 (45%) of 11 paragangliomas without known metastatic disease (1 splice site, 1 deletion causing a frameshift, and 3 missense changes). In 12 malignant pheochromocytomas, 1 SDHD and no SDHB mutations were identified. The identical SDHB mutation was detected in DNA extracted from accompanying normal tissue for each of the 10 cases on which this analysis was performed. An excess of SDHB mutations in paragangliomas versus pheochromocytomas was found, with no difference in the frequency of mutations in malignant versus benign paragangliomas. The disparate mutational spectra in malignant paragangliomas and pheochromocytomas may reflect differences in underlying tumor biology.

KW - Chromaffin tumor

KW - Mitochondrial complex II

KW - Paraganglioma

KW - Pheochromocytoma

KW - SDHB

KW - SDHD

KW - Succinate dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=47049105416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47049105416&partnerID=8YFLogxK

U2 - 10.1097/PDM.0b013e318150d67c

DO - 10.1097/PDM.0b013e318150d67c

M3 - Article

C2 - 18382370

AN - SCOPUS:47049105416

VL - 17

SP - 94

EP - 100

JO - Diagnostic Molecular Pathology

JF - Diagnostic Molecular Pathology

SN - 1052-9551

IS - 2

ER -